Use of rapamycin slows progression of cardiac transplantation vasculopathy

Author： Mancini D.   Pinney S.   Burkhoff D.  

Publisher： Elsevier

ISSN： 1062-1458

Source： ACC Current Journal Review, Vol.12, Iss.6, 2003-11, pp. : 44-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 206-215

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy

By Doshi A.A.   Rogers J.   Kern M.J.   Hauptman P.J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 90-92

Elsevier

Access to resources Recommend Favorite

Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 8, Iss. 5, 2010-09 ,pp. : 706-719

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions

By  

Current Vascular Pharmacology, Vol. 8, Iss. 2, 2010-03 ,pp. : 169-188

Bentham Science Publishers

Access to resources Recommend Favorite

Cerebrovascular Disease as a Complication of Cardiac Transplantation

By  

Cerebrovascular Diseases, Vol. 19, Iss. 4, 2005-04 ,pp. : 267-271

Karger

Access to resources Recommend Favorite